<?xml version="1.0" encoding="UTF-8"?><xml><records><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Malliori, M.</style></author><author><style face="normal" font="default" size="100%">Sypsa, V</style></author><author><style face="normal" font="default" size="100%">Psichogiou, M</style></author><author><style face="normal" font="default" size="100%">Touloumi, G.</style></author><author><style face="normal" font="default" size="100%">Skoutelis, A</style></author><author><style face="normal" font="default" size="100%">Tassopoulos, N.</style></author><author><style face="normal" font="default" size="100%">Hatzakis, A</style></author><author><style face="normal" font="default" size="100%">Stefanis, C</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">A survey of bloodborne viruses and associated risk behaviours in Greek prisons</style></title><secondary-title><style face="normal" font="default" size="100%">AddictionAddictionAddiction</style></secondary-title><alt-title><style face="normal" font="default" size="100%">Addiction</style></alt-title><short-title><style face="normal" font="default" size="100%">AddictionAddiction</style></short-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">*Prisoners</style></keyword><keyword><style  face="normal" font="default" size="100%">Adult</style></keyword><keyword><style  face="normal" font="default" size="100%">Cross-Sectional Studies</style></keyword><keyword><style  face="normal" font="default" size="100%">Female</style></keyword><keyword><style  face="normal" font="default" size="100%">Greece/epidemiology</style></keyword><keyword><style  face="normal" font="default" size="100%">Hepatitis, Viral, Human/*epidemiology</style></keyword><keyword><style  face="normal" font="default" size="100%">HIV Infections/*epidemiology</style></keyword><keyword><style  face="normal" font="default" size="100%">Humans</style></keyword><keyword><style  face="normal" font="default" size="100%">Male</style></keyword><keyword><style  face="normal" font="default" size="100%">Prevalence</style></keyword><keyword><style  face="normal" font="default" size="100%">Risk Factors</style></keyword><keyword><style  face="normal" font="default" size="100%">Risk-Taking</style></keyword><keyword><style  face="normal" font="default" size="100%">Substance-Related Disorders/epidemiology</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">1998</style></year><pub-dates><date><style  face="normal" font="default" size="100%">Feb</style></date></pub-dates></dates><number><style face="normal" font="default" size="100%">2</style></number><volume><style face="normal" font="default" size="100%">93</style></volume><pages><style face="normal" font="default" size="100%">243-51</style></pages><isbn><style face="normal" font="default" size="100%">0965-2140 (Print)0965-2140 (Linking)</style></isbn><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">AIMS: To determine HIV and hepatitis infection prevalence and correlates with risk behaviour. DESIGN: Cross-sectional study: voluntary, anonymous HIV, hepatitis (HCV, HBV and HDV) surveillance and questionnaire on risk factors. SETTING: Korydallos Prison, Athens and Ag. Stefanos Prison, Patra, Greece. PARTICIPANTS: Of 544 drug users imprisoned for drug related offences, all completed the questionnaire and 533 blood samples were collected. MEASUREMENTS: HIV (by anti-HIV-1), HCV (by anti-HCV), HBV (by anti-HBc, HBsAg) and HDV (by anti-HDV) prevalence. Data on demography, legal status, drug use, sharing of injecting equipment. FINDINGS: Of the 544 drug users, 375 (68.9%) had injected drugs (IDUs) at some time, 35% of whom had injected whilst in that prison. Of the 533 blood samples tested, one was positive for anti-HIV-1 (0.19%), 310 for anti-HCV (58.2%), 306/531 (57.6%) for anti-HBc, 34/527 (6.5%) for HBsAg and 12/527 (2.3%) for anti-HDV. Prevalence rates for IDUs only were 0.27% for HIV-1, 80.6% for hepatitis C, 62.7% for hepatitis B and 3.3% for hepatitis D. Ninety-two per cent of IDUs injecting in prison shared needles, indicating that IDUs inject less but share more during incarceration. Multiple logistic regression revealed needle-sharing as the most important risk factor for HCV infection in IDUs. Prior knowledge of a positive hepatitis result did not appear to inhibit IDUs from practising risky behaviours in prison. CONCLUSIONS: The epidemic of hepatitis B and C among imprisoned IDUs identified by this study constitutes a major public health problem. Prevention programmes, such as counselling, HBV vaccination, community-based methadone maintenance treatment and syringe exchange schemes, are necessary in order to prevent a further spread.</style></abstract><accession-num><style face="normal" font="default" size="100%">9624725</style></accession-num><notes><style face="normal" font="default" size="100%">Malliori, MSypsa, VPsichogiou, MTouloumi, GSkoutelis, ATassopoulos, NHatzakis, AStefanis, CengEnglandAbingdon, England1998/06/13 00:00Addiction. 1998 Feb;93(2):243-51. doi: 10.1046/j.1360-0443.1998.9322438.x.</style></notes><auth-address><style face="normal" font="default" size="100%">Department of Psychiatry, University of Athens, Greece.</style></auth-address></record></records></xml>